Journal article · 2023
Rational Design of Bioorthogonally Activatable PROTAC for Tumor-Targeted Protein Degradation
Journal of Medicinal Chemistry, 66(21), 14843–14852 · Published 23 October 2023 · DOI 10.1021/acs.jmedchem.3c01423
In brief
“Rational Design of Bioorthogonally Activatable PROTAC for Tumor-Targeted Protein Degradation” is a 2023 journal article by Tao Bi and 9 co-authors, published in Journal of Medicinal Chemistry. OpenAlex counts 54 citations as of 19 November 2026, which puts it in the top 1% of works published in 2023 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 54
- Most cited in
- 2026 (27)
- Field-weighted impact
- 3.81
- References
- 33
- Authors
- 10
Abstract
Protein degradation mediated by the proteolysis-targeting chimera (PROTAC) has emerged as an efficient strategy to accurately control intracellular protein levels. However, the development of PROTACs is limited by their systemic toxicity. Herein, we report a bioorthogonally activatable prodrug (BT-PROTAC) strategy to accurately control the activity of PROTACs. As a proof of concept, we introduced the… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Bi, T., Pan, L., Zhou, Y., Wang, H., Huang, R., Sun, Q., Shen, H., Yang, S., Ren, W., & Liu, Z. (2023). Rational Design of Bioorthogonally Activatable PROTAC for Tumor-Targeted Protein Degradation. Journal of Medicinal Chemistry, 66(21), 14843–14852. https://doi.org/10.1021/acs.jmedchem.3c01423
MLA 9
Bi, Tao, et al. “Rational Design of Bioorthogonally Activatable PROTAC for Tumor-Targeted Protein Degradation.” Journal of Medicinal Chemistry, vol. 66, no. 21, 2023, pp. 14843–14852. https://doi.org/10.1021/acs.jmedchem.3c01423.
Chicago
Bi, Tao, Liang Pan, Yanan Zhou, Hong Wang, Rui Huang, Qin Sun, Hongping Shen, Sijin Yang, Wei Ren, and Zengjin Liu. 2023. “Rational Design of Bioorthogonally Activatable PROTAC for Tumor-Targeted Protein Degradation.” Journal of Medicinal Chemistry 66 (21): 14843–14852. https://doi.org/10.1021/acs.jmedchem.3c01423.
Harvard
Bi, T. et al. (2023) ‘Rational Design of Bioorthogonally Activatable PROTAC for Tumor-Targeted Protein Degradation’, Journal of Medicinal Chemistry, 66(21), pp. 14843–14852. doi:10.1021/acs.jmedchem.3c01423.
IEEE
T. Bi et al., “Rational Design of Bioorthogonally Activatable PROTAC for Tumor-Targeted Protein Degradation,” Journal of Medicinal Chemistry, vol. 66, no. 21, pp. 14843–14852, 2023, doi: 10.1021/acs.jmedchem.3c01423.
BibTeX
@article{bi2023rational,
title = {{Rational Design of Bioorthogonally Activatable PROTAC for Tumor-Targeted Protein Degradation}},
author = {Bi, Tao and Pan, Liang and Zhou, Yanan and Wang, Hong and Huang, Rui and Sun, Qin and Shen, Hongping and Yang, Sijin and Ren, Wei and Liu, Zengjin},
journal = {Journal of Medicinal Chemistry},
year = {2023},
volume = {66},
number = {21},
pages = {14843--14852},
doi = {10.1021/acs.jmedchem.3c01423},
url = {https://doi.org/10.1021/acs.jmedchem.3c01423}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2024 | 11 | |
| 2025 | 16 | |
| 2026 | 27 |
Its field-weighted citation impact is 3.81: it has been cited 3.81 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- PROTACs
- prodrugs
- trans-cyclooctene
- tetrazine
- BRD4 degradation
- structure-activity relationship
- MZ1
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Bi, T., Pan, L., Zhou, Y., Wang, H., Huang, R., Sun, Q., Shen, H., Yang, S., Ren, W., & Liu, Z. (2023). Rational Design of Bioorthogonally Activatable PROTAC for Tumor-Targeted Protein Degradation. Journal of Medicinal Chemistry, 66(21), 14843–14852. https://doi.org/10.1021/acs.jmedchem.3c01423
How many times has this paper been cited?
54 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Tao Bi, Liang Pan, Yanan Zhou, Hong Wang, Rui Huang, Qin Sun, Hongping Shen, Sijin Yang, Wei Ren, Zengjin Liu.
What is the DOI of this paper?
10.1021/acs.jmedchem.3c01423, permanently at https://doi.org/10.1021/acs.jmedchem.3c01423. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.